Adalimumab-induced bronchospasm: Not a class effect

Thorax

Volumn 63, Issue 5, 2008, Pages 472-473

  Janssen, R ^a   Krivokuca, I ^b   Kruize, A A ^b   Koenderman, L ^b   Lammers, J W J ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BUDESONIDE PLUS FORMOTEROL; ETANERCEPT; INFLIXIMAB; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; PREDNISOLONE;

ADULT; ANAMNESIS; BLOOD CELL COUNT; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXEMIA; LETTER; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRONCHIAL SPASM; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 43749095669     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.086512     Document Type: Letter

References (3)

1. Bennett AN, Wong M, Zain A, et al. Adalimumab-induced asthma. Rheumatology 2005;44:1199-200.
2. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med 2006;354:697-708.
3. Erin EM, Leaker BR, Nicholson GC, et al. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 2006;174:753-62.